The second Cambridge Precision Breast Cancer Symposium

January 30, 2024

The second Cambridge Precision Breast Cancer Symposium #CPBC2024 is being held on the 22nd March at The Old Divinity School, St John’s College Cambridge. A fantastic line up of speakers have confirmed. Poster abstracts can be submitted – from which  we will select at least two for 5min flash presentations; and a competition with £50 prizes available.

The Symposium is an opportunity to meet researchers, clinicians and other specialists from a range of Cambridge institutes and beyond, involved in all aspects of breast cancer research.

Available spaces were sold out last year so we recommend booking early. Please also submit your poster abstract so that you have a chance of being selected for a presentation.

Booking is on Eventbrite https://www.eventbrite.co.uk/e/cambridge-precision-breast-cancer-symposium-2024-tickets-768891313617

Contact the Breast Cancer Programme Manager, Jo Worley, at info@breast.cancer.cam.ac.uk with any questions.

Speakers include:

  • René Bernards, Professor of molecular carcinogenesis, Utrecht University & molecular oncologist, The Netherlands Cancer Institute .
  • Rebecca Burrell, NIHR Academic Clinical Lecturer in medical oncology, Department of Oncology, University of Cambridge.
  • Seth Colbert, Professor of Cancer Immunology , School of Cancer Sciences, University of Glasgow.
  • Dame Lesley Fallowfield, Professor of Psycho-oncology, Brighton and Sussex Medical School.
  • Fiona Gilbert, Professor of Radiology, University of Cambridge School of Clinical Medicine & Honorary Consultant Radiologist, Cambridge University Hospitals NHS Foundation Trust.
  • Greg Hannon, Director of Cancer Research UK Cambridge Institute & Royal Society Research Professor of Molecular Cancer Biology.
  • Sankari Nagarajan, Lecturer in Chromatin Biology, CRUK Career Establishment Award holder, Division of Molecular & Cellular Function, The University of Manchester.
  • Mark O’Connor, Chief Scientist, Early Oncology Discovery & head of DNA Damage Response (DDR), AstraZeneca, Cambridge .
  • Andrew Tutt, Professor of oncology, Head of the Division of Breast Cancer Research & Director of the Breast Cancer Now Toby Robins Research Centre at the Institute of Cancer Research & Guy’s Hospital King’s College London.

The second Cambridge Precision Breast Cancer Symposium
Connect

Connect with us

The Mark Foundation Institute for Integrated Cancer Medicine (MFICM) at the University of Cambridge aims to revolutionise cancer care by affecting patients along their treatment pathway.

Find out more

Connect